Cutler Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.04M Sell
114,555
-323
-0.3% -$26.1K 0.85% 40
2026
Q1
$10M Sell
114,878
-2,601
-2% -$249K 1.03% 33
2025
Q4
$11.4M Sell
117,479
-2,634
-2% -$256K 1.18% 25
2025
Q3
$11.5M Sell
120,113
-654
-0.5% -$60.1K 1.21% 25
2025
Q2
$10.6M Sell
120,767
-346
-0.3% -$29.3K 1.18% 29
2025
Q1
$11M Sell
121,113
-1,229
-1% -$110K 1.32% 26
2024
Q4
$9.86M Sell
122,342
-4,690
-4% -$406K 1.23% 33
2024
Q3
$11.5M Sell
127,032
-1,675
-1% -$141K 1.45% 25
2024
Q2
$10.2M Sell
128,707
-1,391
-1% -$114K 1.39% 33
2024
Q1
$11.4M Buy
130,098
+515
+0.4% +$44K 1.53% 27
2023
Q4
$10.8M Sell
129,583
-60
-0% -$4.57K 1.54% 26
2023
Q3
$10.2M Buy
129,643
+53,667
+71% +$4.49M 1.61% 26
2023
Q2
$6.75M Sell
75,976
-232
-0.3% -$20K 1.02% 39
2023
Q1
$6.2M Buy
76,208
+583
+0.8% +$47.5K 0.96% 40
2022
Q4
$5.93M Sell
75,625
-3,555
-4% -$288K 0.91% 42
2022
Q3
$6.45M Sell
79,180
-113
-0.1% -$10.2K 1.07% 36
2022
Q2
$7.17M Buy
79,293
+675
+0.9% +$68.4K 1.13% 35
2022
Q1
$8.72M Buy
78,618
+1,841
+2% +$194K 1.21% 33
2021
Q4
$7.94M Buy
76,777
+888
+1% +$103K 1.2% 37
2021
Q3
$9.51M Sell
75,889
-4,763
-6% -$616K 1.5% 26
2021
Q2
$10M Buy
80,652
+50
+0.1% +$6.28K 1.57% 24
2021
Q1
$9.52M Buy
80,602
+348
+0.4% +$40.8K 1.65% 22
2020
Q4
$9.4M Sell
80,254
-317
-0.4% -$34.9K 1.72% 23
2020
Q3
$8.37M Buy
80,571
+148
+0.2% +$14.9K 1.62% 27
2020
Q2
$7.38M Sell
80,423
-515
-0.6% -$49.4K 1.57% 28
2020
Q1
$7.3M Sell
80,938
-346
-0.4% -$36.8K 1.76% 26
2019
Q4
$9.22M Sell
81,284
-12,902
-14% -$1.42M 1.85% 23
2019
Q3
$10.2M Buy
94,186
+361
+0.4% +$37.7K 1.97% 20
2019
Q2
$9.14M Sell
93,825
-790
-0.8% -$72.1K 1.76% 25
2019
Q1
$8.62M Sell
94,615
-96
-0.1% -$8.59K 1.69% 29
2018
Q4
$8.62M Buy
94,711
+12,257
+15% +$1.15M 1.85% 23
2018
Q3
$8.11M Buy
82,454
+696
+0.9% +$64.3K 1.52% 32
2018
Q2
$7M Buy
+81,758
New +$6.83M 1.38% 36

Other funds holding MDT

Cutler Investment Counsel's MDT Position: Q2 2026 in Review

Cutler Investment Counsel reduced its Medtronic (MDT) stake by 0.28% in Q2 2026, selling an estimated $26.1K and leaving 114,555 shares worth $9.04M. The position accounts for 0.85% of the portfolio, ranked #40.

Cutler Investment Counsel first reported a position in MDT in Q2 2018 and has held it in 33 quarters since. The position peaked at $11.5M in Q3 2024. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cutler Investment Counsel held 114,555 shares of Medtronic worth $9.04M as of Q2 2026.
  • Cutler Investment Counsel sold 323 Medtronic shares in Q2 2026, an estimated $26.1K.
  • Medtronic made up 0.85% of Cutler Investment Counsel's portfolio in Q2 2026, its #40 holding.
  • Cutler Investment Counsel first reported a position in Medtronic in Q2 2018 and has held it in 33 quarters since.
  • Cutler Investment Counsel's Medtronic position peaked at $11.5M in Q3 2024.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cutler Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.